Ubiquitin-specific protease 2b negatively regulates IFN-β production and antiviral activity by targeting TANK-binding kinase 1

Journal of Immunology

Volumn 193, Issue 5, 2014, Pages 2230-2237

  Zhang, Lei ^a   Zhao, Xueying ^a   Zhang, Meng ^a   Zhao, Wei ^a   Gao, Chengjiang ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; DEUBIQUITINASE; PHOSPHOTRANSFERASE; POLYUBIQUITIN; RETINOIC ACID INDUCIBLE PROTEIN I; TANK BINDING KINASE 1; UBIQUITIN SPECIFIC PROTEASE 2B; UNCLASSIFIED DRUG; PROTEIN SERINE THREONINE KINASE; PROTEINASE; TBK1 PROTEIN, HUMAN; USP2 PROTEIN, HUMAN;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HOST CELL; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREGULATION; INNATE IMMUNITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN SYNTHESIS REGULATION; PROTEIN TARGETING; RETINOIC ACID INDUCIBLE GENE I; SIGNAL TRANSDUCTION; UBIQUITINATION; VESICULAR STOMATITIS VIRUS; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS REPLICATION; GENE SILENCING; GENETICS; HEK293 CELL LINE; IMMUNOLOGY; PHYSIOLOGY; VESICULOVIRUS;

ENDOPEPTIDASES; ENZYME ACTIVATION; GENE KNOCKDOWN TECHNIQUES; HEK293 CELLS; HUMANS; INTERFERON-BETA; POLYUBIQUITIN; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; UBIQUITINATION; VESICULOVIRUS; VIRUS REPLICATION;

EID: 84907031386     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302634     Document Type: Article

References (38)

1. Takeuchi, O., and S. Akira. 2010. Pattern recognition receptors and inflammation. Cell 140: 805-820.
2. Goubau, D., S. Deddouche, and C. Reis e Sousa. 2013. Cytosolic sensing of viruses. Immunity 38: 855-869.
3. Paludan, S. R., and A. G. Bowie. 2013. Immune sensing of DNA. Immunity 38: 870-880.
4. Kawai, T., K. Takahashi, S. Sato, C. Coban, H. Kumar, H. Kato, K. J. Ishii, O. Takeuchi, and S. Akira. 2005. IPS-1, an adaptor triggering RIG-I- and Mda5- mediated type I interferon induction. Nat. Immunol. 6: 981-988.
5. Meylan, E., J. Curran, K. Hofmann, D. Moradpour, M. Binder, R. Bartenschlager, and J. Tschopp. 2005. Cardif is an adaptor protein in the RIGI antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172.
6. Seth, R. B., L. Sun, C. K. Ea, and Z. J. Chen. 2005. Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682.
7. Xu, L.G.,Y.Y.Wang, K. J. Han, L.Y. Li, Z. Zhai, andH.B. Shu. 2005.VISAis an adapter protein required for virus-triggered IFN-β signaling. Mol. Cell 19: 727-740.
8. Sun, L., J. Wu, F. Du, X. Chen, and Z. J. Chen. 2013. Cyclic GMP-AMP synthaseis a cytosolic DNA sensor that activates the type I interferon pathway. Science 339: 786-791.
9. Unterholzner, L., S. E. Keating, M. Baran, K. A. Horan, S. B. Jensen, S. Sharma, C. M. Sirois, T. Jin, E. Latz, T. S. Xiao, et al. 2010. IFI16 is an innate immune sensor for intracellular DNA. Nat. Immunol. 11: 997-1004.
10. Parvatiyar, K., Z. Zhang, R. M. Teles, S. Ouyang, Y. Jiang, S. S. Iyer, S. A. Zaver, M. Schenk, S. Zeng, W. Zhong, et al. 2012. The helicase DDX41 recognizes the bacterial secondary messengers cyclic di-GMP and cyclic di-AMP to activate a type I interferon immune response. Nat. Immunol. 13: 1155-1161.
11. Holm, C. K., S. R. Paludan, and K. A. Fitzgerald. 2013. DNA recognition in immunity and disease. Curr. Opin. Immunol. 25: 13-18.
12. Cavlar, T., A. Ablasser, and V. Hornung. 2012. Induction of type I IFNs by intracellular DNA-sensing pathways. Immunol. Cell Biol. 90: 474-482.
13. Oshiumi, H., M. Matsumoto, and T. Seya. 2012. Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J. Biochem. 151: 5-11.
14. Nijman, S. M., M. P. Luna-Vargas, A. Velds, T. R. Brummelkamp, A. M. Dirac, T. K. Sixma, and R. Bernards. 2005. A genomic and functional inventory of deubiquitinating enzymes. Cell 123: 773-786.
15. Lin, R., L. Yang, P. Nakhaei, Q. Sun, E. Sharif-Askari, I. Julkunen, and J. Hiscott. 2006. Negative regulation of the retinoic acid-inducible gene I-induced antiviral state by the ubiquitin-editing protein A20. J. Biol. Chem. 281: 2095-2103.
16. Kayagaki, N., Q. Phung, S. Chan, R. Chaudhari, C. Quan, K. M. O'Rourke, M. Eby, E. Pietras, G. Cheng, J. F. Bazan, et al. 2007. DUBA: a deubiquitinase that regulates type I interferon production. Science 318: 1628-1632.
17. Zhang, M., X. Wu, A. J. Lee, W. Jin, M. Chang, A. Wright, T. Imaizumi, and S. C. Sun. 2008. Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J. Biol. Chem. 283: 18621-18626.
18. Chen, R., L. Zhang, B. Zhong, B. Tan, Y. Liu, and H. B. Shu. 2010. The ubiquitin-specific protease 17 is involved in virus-triggered type I IFN signaling. Cell Res. 20: 802-811.
19. Wang, L., W. Zhao, M. Zhang, P. Wang, K. Zhao, X. Zhao, S. Yang, and C. Gao. 2013. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J. Virol. 87: 4507-4515.
20. Zhang, M., L. Wang, X. Zhao, K. Zhao, H. Meng, W. Zhao, and C. Gao. 2012. TRAF-interacting protein (TRIP) negatively regulates IFN-β production and antiviral response by promoting proteasomal degradation of TANK-binding kinase 1. J. Exp. Med. 209: 1703-1711.
21. Zhao, W., L. Wang, M. Zhang, P. Wang, C. Yuan, J. Qi, H. Meng, and C. Gao. 2012. Tripartite motif-containing protein 38 negatively regulates TLR3/4- and RIG-I-mediated IFN-β production and antiviral response by targeting NAP1. J. Immunol. 188: 5311-5318.
22. Baek, S. H., K. S. Choi, Y. J. Yoo, J. M. Cho, R. T. Baker, K. Tanaka, and C. H. Chung. 1997. Molecular cloning of a novel ubiquitin-specific protease, UBP41, with isopeptidase activity in chick skeletal muscle. J. Biol. Chem. 272: 25560-25565.
23. Wathelet, M. G., C. H. Lin, B. S. Parekh, L. V. Ronco, P. M. Howley, and T. Maniatis. 1998. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-β enhancer in vivo. Mol. Cell 1: 507-518.
24. Tu, D., Z. Zhu, A. Y. Zhou, C. H. Yun, K. E. Lee, A. V. Toms, Y. Li, G. P. Dunn, E. Chan, T. Thai, et al. 2013. Structure and ubiquitination-dependent activation of TANK-binding kinase 1. Cell Reports 3: 747-758.
25. Wang, C., T. Chen, J. Zhang, M. Yang, N. Li, X. Xu, and X. Cao. 2009. The E3 ubiquitin ligase Nrdp1 'preferentially' promotes TLR-mediated production of type I interferon. Nat. Immunol. 10: 744-752.
26. Kawai, T., and S. Akira. 2010. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat. Immunol. 11: 373-384.
27. Loo, Y. M., and M. Gale, Jr. 2011. Immune signaling by RIG-I-like receptors. Immunity 34: 680-692.
28. Lei, C. Q., B. Zhong, Y. Zhang, J. Zhang, S. Wang, and H. B. Shu. 2010. Glycogen synthase kinase 3b regulates IRF3 transcription factor-mediated antiviral response via activation of the kinase TBK1. Immunity 33: 878-889.
29. Li, S., L. Wang, M. Berman, Y. Y. Kong, and M. E. Dorf. 2011. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35: 426-440.
30. Cui, J., Y. Li, L. Zhu, D. Liu, Z. Songyang, H. Y. Wang, and R. F. Wang. 2012. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin ligase DTX4. Nat. Immunol. 13: 387-395.
31. Saitoh, T., M. Yamamoto, M. Miyagishi, K. Taira, M. Nakanishi, T. Fujita, S. Akira, N. Yamamoto, and S. Yamaoka. 2005. A20 is a negative regulator of IFN regulatory factor 3 signaling. J. Immunol. 174: 1507-1512.
32. Parvatiyar, K., G. N. Barber, and E. W. Harhaj. 2010. TAX1BP1 and A20 inhibit antiviral signaling by targeting TBK1-IKKi kinases. J. Biol. Chem. 285: 14999-15009.
33. Gao, L., H. Coope, S. Grant, A. Ma, S. C. Ley, and E. W. Harhaj. 2011. ABIN1 protein cooperates with TAX1BP1 and A20 proteins to inhibit antiviral signaling. J. Biol. Chem. 286: 36592-36602.
34. He, X., Y. Li, C. Li, L. J. Liu, X. D. Zhang, Y. Liu, and H. B. Shu. 2013. USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6. J. Mol. Cell Biol. 5: 39-47.
35. Mahul-Mellier, A. L., E. Pazarentzos, C. Datler, R. Iwasawa, G. AbuAli, B. Lin, and S. Grimm. 2012. De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF. Cell Death Differ. 19: 891-899.
36. Stevenson, L. F., A. Sparks, N. Allende-Vega, D. P. Xirodimas, D. P. Lane, and M. K. Saville. 2007. The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J. 26: 976-986.
37. Haimerl, F., A. Erhardt, G. Sass, and G. Tiegs. 2009. Down-regulation of the deubiquitinating enzyme ubiquitin-specific protease 2 contributes to tumor necrosis factor-a-induced hepatocyte survival. J. Biol. Chem. 284: 495-504.
38. Molusky, M. M., S. Li, D. Ma, L. Yu, and J. D. Lin. 2012. Ubiquitin-specific protease 2 regulates hepatic gluconeogenesis and diurnal glucose metabolism through 11b-hydroxysteroid dehydrogenase 1. Diabetes 61: 1025-1035.